ProfileGDS4718 / 225206_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 84% 82% 87% 86% 86% 86% 83% 86% 87% 90% 85% 85% 82% 85% 82% 85% 83% 82% 77% 85% 85% 86% 87% 84% 82% 85% 79% 84% 82% 74% 84% 85% 86% 82% 83% 87% 82% 85% 83% 84% 78% 81% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8016387
GSM549102patient 115, normal, homogenized [OPG study]8.2727384
GSM549104patient 119, normal, homogenized [OPG study]8.1887982
GSM549108patient 138, normal, homogenized [OPG study]8.5839787
GSM549119patient 077, normal, homogenized [OPG study]8.5564986
GSM549133patient 032, cancer, homogenized [OPG study]8.7741486
GSM549139patient 042, cancer, homogenized [OPG study]8.580686
GSM549099patient 107, normal, homogenized [OPG study]8.1151483
GSM549109patient 139, normal, homogenized [OPG study]8.5438186
GSM549110patient 046, normal, homogenized [OPG study]8.8051187
GSM549114patient 063, normal, homogenized [OPG study]9.4201890
GSM549122patient 082, normal, homogenized [OPG study]8.4669285
GSM549134patient 033, cancer, homogenized [OPG study]8.4990185
GSM549136patient 036, cancer, homogenized [OPG study]8.1795982
GSM549140patient 044, cancer, homogenized [OPG study]8.5105885
GSM549111patient 047, normal, homogenized [OPG study]8.1397582
GSM549113patient 057, normal, homogenized [OPG study]8.6733485
GSM549132patient 031, cancer, homogenized [OPG study]8.1576183
GSM549137patient 038, cancer, homogenized [OPG study]8.1105582
GSM549142patient 047, cancer, homogenized [OPG study]7.3820677
GSM549100patient 110, normal, homogenized [OPG study]8.4169785
GSM549107patient 135, normal, homogenized [OPG study]8.4582685
GSM549115patient 068, normal, homogenized [OPG study]8.7814986
GSM549116patient 072, normal, homogenized [OPG study]8.8137987
GSM549120patient 078, normal, homogenized [OPG study]8.3625284
GSM549131patient 030, cancer, homogenized [OPG study]8.1771382
GSM549118patient 074, normal, homogenized [OPG study]8.4997585
GSM549129patient 027, cancer, homogenized [OPG study]7.8026279
GSM549123patient 088, normal, homogenized [OPG study]8.3144784
GSM549124patient 006, cancer, homogenized [OPG study]8.0172982
GSM549126patient 015, cancer, homogenized [OPG study]7.2636874
GSM549128patient 025, cancer, homogenized [OPG study]8.4118184
GSM549103patient 117, normal, homogenized [OPG study]8.2594385
GSM549117patient 073, normal, homogenized [OPG study]8.6571486
GSM549138patient 041, cancer, homogenized [OPG study]8.1043182
GSM549141patient 045, cancer, homogenized [OPG study]8.3791483
GSM549130patient 028, cancer, homogenized [OPG study]8.6619787
GSM549101patient 111, normal, homogenized [OPG study]8.0238182
GSM549105patient 128, normal, homogenized [OPG study]8.3881485
GSM549106patient 134, normal, homogenized [OPG study]8.3496883
GSM549112patient 048, normal, homogenized [OPG study]8.3701984
GSM549125patient 011, cancer, homogenized [OPG study]7.6109978
GSM549127patient 024, cancer, homogenized [OPG study]7.9636481
GSM549135patient 035, cancer, homogenized [OPG study]8.6283385